Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype
NCT00808184Phase 4Completed
- Sponsor
- National University Hospital
- Start
- Apr 2010
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir, midazolam, irinotecan in solid tumor, sponsored by National University Hospital. Started Apr 2010; status: completed.
02
Drugs
raltegravirmidazolamirinotecan
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00808184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808184.